Search Within

David Hyman

  1. "Cancer Research"
Formats
  1. Meeting Abstract (30)
  2. Journal Article (2)
Groups
  1. Department of Medicine (32)
  2. Early Drug Development Service (32)
  3. Solid Tumor Oncology Division (32)
  4. GSK Faculty (22)
  5. Human Oncology and Pathogenesis Program (22)
  6. Department of Pathology and Laboratory Medicine (17)

More Groups

People
  1. David Solit (13)
  2. Michael Berger (13)
  3. Alison Schram (10)
  4. Marc Ladanyi (10)
  5. Ahmet Zehir (9)
  6. Jose Baselga (9)

More People

Years
  1. 2020 (6)
  2. 2019 (15)
  3. 2018 (5)
  4. 2017 (3)
  5. 2016 (1)
  6. 2015 (2)
Publications
  1. Cancer Research (32)
Publishers
  1. American Association for Cancer Research (32)

Results (32)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The utility of plasma ctDNA for detection of KRAS G12C and other mutations in lung cancers
    Meeting Abstract

    Murciano-Goroff, Y. R.; Arbour, K. C.; Offin, M. D.; Tu, H. Y. Y.; Lebow, E. S.; Shaffer, T. S.; Bertucci, C.; Hosseini, S. A.; Garg, K.; Lim, L. P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Kinase fusions drive endocrine resistance in estrogen receptor-positive breast cancer
    Meeting Abstract

    Liu, B.; Ross, D. S.; Schram, A. M.; Razavi, P.; Lagana, S. M.; Zhang, Y.; Scaltriti, M.; Bromberg, J. F.; Ladanyi, M.; Hyman, D. M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
    Meeting Abstract

    Cocco, E.; Lee, J. E.; Kannan, S.; Schram, A. M.; Won, H. H.; Shifman, S.; Kulick, A.; Baldino, L.; Toska, E.; Arena, S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Oncologic therapy shapes the fitness landscape of clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; Coombs, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Neratinib + trastuzumab + fulvestrant for HER2-mutant, hormone receptor-positive, metastatic breast cancer: Updated results from the phase 2 SUMMIT 'basket' trial
    Meeting Abstract

    Wildiers, H.; Boni, V.; Saura, C.; Oliveira, M.; Jhaveri, K.; Won, H.; Bidard, F. C.; Brufsky, A. M.; Burkard, M. E.; Cervantes, A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Capivasertib (AZD5363) in combination with fulvestrant in PTEN-mutant ER+ metastatic breast cancer
    Meeting Abstract

    Smyth, L. M.; Batist, G.; Meric-Bernstam, F.; Kabos, P.; Spanggaard, I.; Lluch, A.; Schram, A.; Varga, A.; Wong, A.; Ambrose, H.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Clinical validation of a genomics-based classifier to predict tissue of origin from targeted tumor sequencing
    Meeting Abstract

    Zheng, Y.; Penson, A. V.; Camacho, N.; Biederstedt, E.; Zehir, A.; Kandoth, C.; Syed, A.; Varghese, A. M.; Al-Ahmadie, H. A.; Schultz, N.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Paired tumor and cfDNA in patients with HER2-mutant solid tumors treated with neratinib reveals convergence of multiple on-target resistance mechanisms: Results from the SUMMIT "Basket" Trial
    Meeting Abstract

    Won, H. H.; Selcuklu, S. D.; Piha-Paul, S. A.; Saura, C.; Rodon, J.; Mayer, I. A.; Loi, S.; Shapiro, G. I.; Lu, J.; Brufsky, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Initial results from the phase I study of MSC-1, a humanized anti-LIF monoclonal antibody, in patients with advanced solid tumors
    Meeting Abstract

    Schram, A.; Spreafico, A.; Oliva, M.; Brana, I.; Garralda, E.; Lakhani, N.; Von Hoff, D.; Borazanci, E.; Pandya, N.; Hoffman, K.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Prospective clinical sequencing distinguishes independent primary cancers from recurrent or metastatic disease
    Meeting Abstract

    Schram, A. M.; Bandlamudi, C.; Zehir, A.; Ladanyi, M.; Berger, M. F.; Taylor, B. S.; Hyman, D. M.
    Cancer Research (2019)

    Fulltext@MSK | Save